|
|
|
2007³â11¿ù19ÀÏ 00½Ã00ºÐ |
|
|
|
|
ÀÌÈÀÇ·á¿ø È«±â¼÷, Á¤È¼ø, ½Å±æÀÚ ±³¼ö SIMENS Çмú»ó ¼ö»ó
|
|
À̴뵿´ë¹®º´¿ø Áø´Ü°Ë»çÀÇÇаú È«±â¼÷, ¼øȯ±â³»°ú ½Å±æÀÚ, ÀÌ´ë¸ñµ¿º´¿ø Áø´Ü°Ë»çÀÇÇаú Á¤È¼ø ±³¼öÀÇ °øµ¿ ³í¹®ÀÌ Áö³ 10¿ù 30~31ÀÏ ±×·£µåÈúÆ°È£ÅÚ¿¡¼ °³ÃÖµÈ ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ Á¦ 48Â÷ Çмú´ëȸ¿¡¼ SIMENS Çмú»óÀ» ¼ö»óÇß´Ù.
¼ö»ó³í¹®Àº ÀÓ»óÈÇа迡¼´Â À¯¸íÇÑ CCLM (Clinical Chemistry and Laboratory Medicine) Àú³Î¿¡ ½Ç¸° ¡®The methylenetetrahydrofolate reductase C677T gene mutation is associated with hyperhomocysteinemia, cardiovascular disease and plasma B-type natriuretic peptide levels in Korea¡¯ ·Î ±¹³»ÃÖÃÊ·Î °íÈ£¸ð½Ã½ºÆ¾Ç÷Áõ À¯¹ß À¯ÀüÀÚ º¯ÀÌ¿Í ½ÉÇ÷°ü Áúȯ ¹× ½ÉºÎÀü Ç¥ÁöÀÚ¿ÍÀÇ °ü·Ã¼ºÀ» Á¦½ÃÇÑ ¿¬±¸·Î Æò°¡¹Þ°í ÀÖ´Ù.
SIMENSÇмú»óÀº SCI¿¡ µîÀçµÈ ³í¹®À» ´ë»óÀ¸·Î ¿ì¼ö³í¹®À» ¼±Á¤ÇÏ´Â »óÀ¸·Î ÀÌ ºÐ¾ß¿¡¼´Â ÃÖ°íÀÇ »óÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù.
|
|
|
|
|
|